-
Je něco špatně v tomto záznamu ?
Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure Matrix
AL. Hall, H. Kromhout, J. Schüz, S. Peters, L. Portengen, R. Vermeulen, A. Agudo, W. Ahrens, P. Boffetta, P. Brennan, C. Canova, DI. Conway, MP. Curado, AW. Daudt, L. Fernandez, M. Hashibe, CM. Healy, I. Holcatova, K. Kjaerheim, R. Koifman, P....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- azbest toxicita MeSH
- karcinogeny * toxicita MeSH
- lidé MeSH
- nádory hrtanu * chemicky indukované epidemiologie MeSH
- nemoci z povolání * chemicky indukované epidemiologie MeSH
- oxid křemičitý toxicita MeSH
- pracovní expozice * škodlivé účinky analýza MeSH
- rizikové faktory MeSH
- studie případů a kontrol MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Various established occupational lung carcinogens are also suspected risk factors for laryngeal cancer. However, individual studies are often inadequate in size to investigate this relatively rare outcome. Other limitations include imprecise exposure assessment and inadequate adjustment for confounders. METHODS: This study applied a quantitative job exposure matrix (SYN-JEM) for four established occupational lung carcinogens to five case-control studies within the International Head and Neck Cancer Epidemiology Consortium. We used occupational histories for 2256 laryngeal cancer cases and 7857 controls recruited from 1989 to 2007. We assigned quantitative exposure levels for asbestos, respirable crystalline silica, chromium-VI, and chromium-VI and nickel combined (to address highly correlated exposures) via SYN-JEM. We assessed effects of occupational exposure on cancer risk for males (asbestos, respirable crystalline silica, chromium-VI, and chromium-VI and nickel combined) and females (asbestos and respirable crystalline silica), adjusting for age, study, tobacco smoking, alcohol consumption, and asbestos exposure where relevant. RESULTS: Among females, odds ratios (ORs) were increased for ever versus never exposed. Among males, P values for linear trend were <0.05 for estimated cumulative exposure (all agents) and <0.05 for exposure duration (respirable crystalline silica, chromium-VI, and chromium-VI and nickel combined); strongest associations were for asbestos at >90th percentile cumulative exposure (OR = 1.3, 95% confidence interval [CI] = 1.0, 1.6), respirable crystalline silica at 30+ years duration (OR = 1.4, 95% CI = 1.2, 1.7) and 75th-90th percentile cumulative exposure (OR = 1.4, 95% CI = 1.1, 1.8), chromium-VI at >75th percentile cumulative exposure (OR = 1.9, 95% CI = 1.2, 3.0), and chromium-VI and nickel combined at 20-29 years duration (OR = 1.5, 95% CI = 1.1, 2.2). CONCLUSIONS: These findings support hypotheses of causal links between four lung carcinogens (asbestos, respirable crystalline silica, chromium-VI, and nickel) and laryngeal cancer.
Aviano Cancer Centre Aviano Italy
Cancer Registry of Norway Institute of Population based Cancer Research Oslo Norway
Department of Medical and Surgical Sciences University of Bologna Bologna Italy
Department of Medical Sciences University of Turin Turin Italy
Epidemiology CIPE ACCAMARGO Sao Paulo Brazil
Escola Nacional de Saude Publica Fundacao Oswaldo Cruz Rio de Janeiro Brazil
Faculty of Mathematics Computer Science Institute of Statistics University of Bremen Bremen Germany
From the International Agency for Research on Cancer Lyon France
Hospital de Clinicas de Porto Alegre Porto Alegre Brazil
Institute for Risk Assessment Sciences Utrecht University The Netherlands
Institute of Oncology and Radiobiology Havana Cuba
Institute of Oncology Angel H Roffo University of Buenos Aires Argentina
Leibniz Institute for Prevention Research and Epidemiology BIPS Bremen Germany
School of Medicine National and Kapodistrian University of Athens Athens Greece
Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York USA
Trinity College School of Dental Science Dublin Ireland
Univ Rennes Inserm EHESP Irset UMR_S 1085 Pointe à Pitre France
Universidade de Sao Paulo Sao Paulo Brazil
Universidade Federal de Pelotas Pelotas Brazil
University of Heidelberg Heidelberg Germany
University of Hong Kong Hong Kong China
University of Padua Padova Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012956
- 003
- CZ-PrNML
- 005
- 20210716111309.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/EDE.0000000000001120 $2 doi
- 035 __
- $a (PubMed)31577634
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hall, Amy L $u From the International Agency for Research on Cancer, Lyon, France
- 245 10
- $a Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure Matrix / $c AL. Hall, H. Kromhout, J. Schüz, S. Peters, L. Portengen, R. Vermeulen, A. Agudo, W. Ahrens, P. Boffetta, P. Brennan, C. Canova, DI. Conway, MP. Curado, AW. Daudt, L. Fernandez, M. Hashibe, CM. Healy, I. Holcatova, K. Kjaerheim, R. Koifman, P. Lagiou, D. Luce, GJ. Macfarlane, A. Menezes, G. Menvielle, J. Polesel, H. Ramroth, L. Richiardi, I. Stücker, P. Thomson, M. Vilensky, V. Wunsch-Filho, AL. Yuan-Chin, A. Znaor, K. Straif, A. Olsson
- 520 9_
- $a INTRODUCTION: Various established occupational lung carcinogens are also suspected risk factors for laryngeal cancer. However, individual studies are often inadequate in size to investigate this relatively rare outcome. Other limitations include imprecise exposure assessment and inadequate adjustment for confounders. METHODS: This study applied a quantitative job exposure matrix (SYN-JEM) for four established occupational lung carcinogens to five case-control studies within the International Head and Neck Cancer Epidemiology Consortium. We used occupational histories for 2256 laryngeal cancer cases and 7857 controls recruited from 1989 to 2007. We assigned quantitative exposure levels for asbestos, respirable crystalline silica, chromium-VI, and chromium-VI and nickel combined (to address highly correlated exposures) via SYN-JEM. We assessed effects of occupational exposure on cancer risk for males (asbestos, respirable crystalline silica, chromium-VI, and chromium-VI and nickel combined) and females (asbestos and respirable crystalline silica), adjusting for age, study, tobacco smoking, alcohol consumption, and asbestos exposure where relevant. RESULTS: Among females, odds ratios (ORs) were increased for ever versus never exposed. Among males, P values for linear trend were <0.05 for estimated cumulative exposure (all agents) and <0.05 for exposure duration (respirable crystalline silica, chromium-VI, and chromium-VI and nickel combined); strongest associations were for asbestos at >90th percentile cumulative exposure (OR = 1.3, 95% confidence interval [CI] = 1.0, 1.6), respirable crystalline silica at 30+ years duration (OR = 1.4, 95% CI = 1.2, 1.7) and 75th-90th percentile cumulative exposure (OR = 1.4, 95% CI = 1.1, 1.8), chromium-VI at >75th percentile cumulative exposure (OR = 1.9, 95% CI = 1.2, 3.0), and chromium-VI and nickel combined at 20-29 years duration (OR = 1.5, 95% CI = 1.1, 2.2). CONCLUSIONS: These findings support hypotheses of causal links between four lung carcinogens (asbestos, respirable crystalline silica, chromium-VI, and nickel) and laryngeal cancer.
- 650 _2
- $a azbest $x toxicita $7 D001194
- 650 12
- $a karcinogeny $x toxicita $7 D002273
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory hrtanu $x chemicky indukované $x epidemiologie $7 D007822
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a nemoci z povolání $x chemicky indukované $x epidemiologie $7 D009784
- 650 12
- $a pracovní expozice $x škodlivé účinky $x analýza $7 D016273
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a oxid křemičitý $x toxicita $7 D012822
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kromhout, Hans $u Institute for Risk Assessment Sciences, Utrecht University, The Netherlands
- 700 1_
- $a Schüz, Joachim $u From the International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Peters, Susan $u Institute for Risk Assessment Sciences, Utrecht University, The Netherlands
- 700 1_
- $a Portengen, Lützen $u Institute for Risk Assessment Sciences, Utrecht University, The Netherlands
- 700 1_
- $a Vermeulen, Roel $u From the International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Agudo, Antonio $u Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
- 700 1_
- $a Ahrens, Wolfgang $u Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany ; Faculty of Mathematics/Computer Science, Institute of Statistics, University of Bremen, Bremen, Germany
- 700 1_
- $a Boffetta, Paolo $u Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA ; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
- 700 1_
- $a Brennan, Paul $u From the International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Canova, Cristina $u University of Padua, Padova, Italy
- 700 1_
- $a Conway, David I $u School of Medicine, Dentistry, and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
- 700 1_
- $a Curado, Maria Paula $u Epidemiology - CIPE/ACCAMARGO, Sao Paulo, Brazil
- 700 1_
- $a Daudt, Alexander W $u Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
- 700 1_
- $a Fernandez, Leticia $u Institute of Oncology and Radiobiology, Havana, Cuba
- 700 1_
- $a Hashibe, Mia $u University of Utah, Salt Lake City, USA
- 700 1_
- $a Healy, Claire M $u Trinity College School of Dental Science, Dublin, Ireland
- 700 1_
- $a Holcatova, Ivana $u Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kjaerheim, Kristina $u Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway
- 700 1_
- $a Koifman, Rosalina $u Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil
- 700 1_
- $a Lagiou, Pagona $u School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Luce, Danièle $u Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France
- 700 1_
- $a Macfarlane, Gary J $u Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, United Kingdom
- 700 1_
- $a Menezes, Ana $u Universidade Federal de Pelotas, Pelotas, Brazil
- 700 1_
- $a Menvielle, Gwenn $u INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Paris, France
- 700 1_
- $a Polesel, Jerry $u Aviano Cancer Centre, Aviano, Italy
- 700 1_
- $a Ramroth, Heribert $u University of Heidelberg, Heidelberg, Germany
- 700 1_
- $a Richiardi, Lorenzo $u Department of Medical Sciences, University of Turin, Turin, Italy
- 700 1_
- $a Stücker, Isabelle $u University Paris Sud, Paris Saclay University, UVSQ, CESP, INSERM, Environmental Epidemiology of Cancer Team, Villejuif, France
- 700 1_
- $a Thomson, Peter $u University of Hong Kong, Hong Kong, China
- 700 1_
- $a Vilensky, Marta $u Institute of Oncology Angel H. Roffo, University of Buenos Aires, Argentina
- 700 1_
- $a Wunsch-Filho, Victor $u Universidade de Sao Paulo, Sao Paulo, Brazil
- 700 1_
- $a Yuan-Chin, Amy Lee $u University of Utah, Salt Lake City, USA
- 700 1_
- $a Znaor, Ariana $u From the International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Straif, Kurt $u From the International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Olsson, Ann $u From the International Agency for Research on Cancer, Lyon, France
- 773 0_
- $w MED00004963 $t Epidemiology (Cambridge, Mass.) $x 1531-5487 $g Roč. 31, č. 1 (2020), s. 145-154
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31577634 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210716111309 $b ABA008
- 999 __
- $a ok $b bmc $g 1651188 $s 1133335
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 31 $c 1 $d 145-154 $e - $i 1531-5487 $m Epidemiology $n Epidemiology $x MED00004963
- LZP __
- $a Pubmed-20210420
